Relmada Therapeutics Q2 EPS USD -0.11
RLMD•Q2 net income
Aug 06 (Reuters) - Relmada Therapeutics Q2 net income USD -12.9 million.
Related News
Canada's IAMGOLD Q2 adjusted EBITDA rises on higher gold prices
IAG•
American Realty Investors swings to Q2 loss on higher operating expenses
ARL•
Hydrofarm completes sale of Aurora Peat Products to Raven Holdings for USD 16 million
HYFM•
Peoples Bancorp of North Carolina Director Robert C. Abernethy reports common stock sale worth $227,425.98
PEBK•
DraftKings Q2 FY26 adjusted EBITDA drops 61.9% to USD 114.6 million; revenue falls 4.6% to USD 1.44 billion
DKNG•